Matthew T. Fornataro

Biden Administration Issues Rules Requiring Insurer Transparency On Drug Spending, Rebates And Fees: What Manufacturers Need To Know

Pharmacy Point-Of-Sale Price Concession And PBM Service Fee Safe Harbor Final Rule May Reshape Medicare Part D: What Pharmaceutical Manufacturers Need To Know Now

Guide To The Trump Administration's Drug Importation Final Rule And Guidance

HHS OIG's Proposed Rule: Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals

Trump Administration Issues Blueprint To Lower Drug Prices And Reduce Out-Of-Pocket Costs